Routes of
administration Oral Excretion 60-70% PubChem CID 2264 Bioavailability 90% | ATC code none CAS Number 123039-99-6 Molar mass 349.81 g/mol | |
 | ||
AHFS/Drugs.com International Drug Names | ||
How to pronounce azasetron
Azasetron is an antiemetic which acts as a 5-HT3 receptor antagonist , pKi = 9.27 It is used in the management of nausea and vomiting induced by cancer chemotherapy (such as cisplatin chemotherapy). Azasetron hydrochloride is given in a usual dose of 10 mg once daily by mouth or intravenously. It is approved for marketing in Japan, and marketed exclusively by Torii Pharmaceutical Co., Ltd. under the trade names "Serotone® I.V. Injection 10 mg" and "Serotone® Tablets 10 mg". Pharmacokinetics data from S. Tsukagoshi.
References
References
Azasetron Wikipedia(Text) CC BY-SA